
Belcourt Pharma Private Limited
About Belcourt Pharma Private Limited
Data last updated:
Belcourt Pharma Private Limited is a private limited company based in Chandigarh, India. It was incorporated on 20 February 2023.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U46497CH2023PTC044903. Its GSTIN is 04AALCB4016D1Z8 (Chandigarh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Narender Pal Singh and Paramjot Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 186, Industrial Area Phase II, Chandigarh, India – 160002.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.3 Lakh, a growth of 33% compared to the previous year. For the same year it recorded a net loss of ₹3,956 (net margin -0.3%) and EBITDA of ₹41,402 (EBITDA margin 3.1%).
Company details
Contact details
Belcourt Pharma Private Limited's registered office is in Chandigarh, Chandigarh.
- Registered AddressPlot No 186, Industrial Area Phase II, Chandigarh, India – 160002
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Belcourt Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Belcourt Pharma Private Limited, buy the company report.
Financials of Belcourt Pharma Private Limited
FY 2025 filings availableBelcourt Pharma Private Limited reported revenue of ₹13.3 Lakh (up 33% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 33% in the latest year. EBITDA rose 50% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹41,402 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹3,956 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 3.1% | ||
| Net Profit Margin | -0.3% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Belcourt Pharma Private Limited, buy the company report.
Board of directors of Belcourt Pharma Private Limited
Belcourt Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Narender Pal Singh Also directs: Medomak Healthcare LLP, Ace Medipharma Private Limited | Director | 20 Feb 2023 | 3 Years 8 Months | Current |
| Paramjot Singh Also directs: Medomak Healthcare LLP, Ace Medipharma Private Limited | Director | 20 Feb 2023 | 3 Years 8 Months | Current |
Peer comparison
Belcourt Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Guru SSR India Distributors Private Limited | ₹13.44 Lakh (FY 2022) | 36.0% | Pune, Maharashtra, India | |||
| Simca Medtech Private Limited | ₹13.43 Lakh (FY 2021) | -79.0% | Delhi, India | |||
| Endovision Pharma Private Limited | ₹13.41 Lakh (FY 2022) | Pune, Maharashtra, India | ||||
| Subhyog Pharmaceuticals Private Limited | ₹13.31 Lakh (FY 2024) | -23.0% | Delhi, India | |||
| Belcourt Pharma Private Limitedthis company | ₹13.3 Lakh (FY 2025) | -₹3,956 | -0.3% | 33.0% | Chandigarh, India | |
| Pharmacia Healthcare Private Limited | ₹13.29 Lakh (FY 2025) | 36.0% | Begusarai, Bihar, India |
To see the full peer comparison of Belcourt Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Belcourt Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Belcourt Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Belcourt Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AALCB4016D1Z8 | Chandigarh | Active | 31 Mar 2023 |
To see the full GST registrations and return filing status of Belcourt Pharma Private Limited, buy the company report.
Recent activity
Belcourt Pharma Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Narender Pal Singh was appointed as Director on 20 Feb 2023.
Frequently asked questions
Belcourt Pharma is an active private limited company based in Chandigarh, India. It was incorporated on 20 February 2023 (3+ years old) and is registered under CIN U46497CH2023PTC044903.
Belcourt Pharma has 2 current directors:
- Narender Pal Singh - Director
- Paramjot Singh - Director
The latest financial statements of Belcourt Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Belcourt Pharma is 04AALCB4016D1Z8, registered in Chandigarh.
The CIN (Corporate Identification Number) of Belcourt Pharma is U46497CH2023PTC044903. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Belcourt Pharma was incorporated on 20 February 2023, making it 3+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Belcourt Pharma by revenue are Guru SSR India Distributors Private Limited, Simca Medtech Private Limited, Endovision Pharma Private Limited, Subhyog Pharmaceuticals Private Limited, Pharmacia Healthcare Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Narender Pal Singh was appointed as Director on 20 Feb 2023. Paramjot Singh was appointed as Director on 20 Feb 2023.
The registered office of Belcourt Pharma is at Plot No 186, Industrial Area Phase II, Chandigarh, India – 160002.
Belcourt Pharma can be reached at its registered office: Plot No 186, Industrial Area Phase II, Chandigarh, India – 160002.
Belcourt Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Chandigarh.

